Bayer Swoops for Norway's Algeta

German drug maker Bayer is in talks to buy Norwegian oncology company Algeta for $2.42 billion, as it seeks full control over potential blockbuster cancer treatment Xofigo.



from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304281004579221530922065594.html?mod=pls_whats_news_us_business_f

via IFTTT